Delivery Order SPE2DB25D3108-SPE2DB25FPBUM
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB24D3013|SPE2DB25FFHSB was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order valued at $3,750.34 with a firm fixed price pricing type. The contract is for MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, and has a completion date of January 6, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $12,221.22 firm fixed-price delivery order is for the supply of Mesalamine DR 1.2 GM tablets. The contract has an ultimate completion date of October 25, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of 120 tablets of Mesalamine delayed-release 1.2 gram tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,612.41 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablet 120S. The $1,541.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,561,559,448 tablets of Mesalamine DR 1.2 GM. The total ceiling value of the delivery order is $3,846.35, with a firm fixed price. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, valued at $12,703.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of 4,565,805,308 units of Mesalamine 800 mg delayed-release tablets in 180-count bottles. This is a delivery order contract with a firm-fixed price, and the ultimate completion date is September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,173.18 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of 180 units of the prescription drug Mesalamine 800 mg delayed release tablets by February 2, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,490.48, is for the delivery of 120 tablets of Mesalamine Delayed-Release 1.2 gram. The contract has a firm fixed price and an ultimate completion date of September 27, 2023. The award was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,734.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564714392 ! MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, with a period of performance through May 28, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with the ID SPE2DX15D1053|SPE2DX25F6DAP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,550.28 firm fixed price delivery order is for the supply of 4,566,374,128 tablets of Mesalamine DR 1.2 GM, a medication used for various medical conditions. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...